KRMD - Repro Med Systems - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRMD is currently covered by 6 analysts with an average price target of $4.67. This is a potential upside of $0.56 (13.63%) from yesterday's end of day stock price of $4.11.

Repro Med Systems's activity chart (see below) currently has 24 price targets and 28 ratings on display. The stock rating distribution of KRMD is 81.82% BUY and 18.18% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.23% with an average time for these price targets to be met of 234.5 days.

Highest price target for KRMD is $5, Lowest price target is $3.5, average price target is $4.

Most recent stock forecast was given by JASON BEDNAR from PIPER SANDLER on 08-May-2025. First documented stock forecast 24-Jun-2020.

Best performing analysts who are covering KRMD - Repro Med Systems:

Kyle Rose Jason Bednar Matt O'brien Frank Takkinen

Currently out of the existing stock ratings of KRMD, 9 are a BUY (81.82%), 2 are a HOLD (18.18%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$3.5

$-0.67 (-16.07%)

$4.5

3 months 13 days ago
(08-May-2025)

5/6 (83.33%)

$0.21 (6.38%)

192

Buy

$4.5

$0.33 (7.91%)

$3.5

6 months 7 days ago
(14-Feb-2025)

2/7 (28.57%)

$0.13 (2.97%)

13

Buy

$5

$0.83 (19.90%)

$4

7 months 7 days ago
(14-Jan-2025)

1/2 (50%)

$0.93 (22.85%)

447

Buy

$3

$-1.17 (-28.06%)

$4

1 years 9 months 12 days ago
(09-Nov-2023)

3/4 (75%)

$0.97 (47.78%)

286

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRMD (Repro Med Systems) average time for price targets to be met?

On average it took 234.5 days on average for the stock forecasts to be realized with a an average price target met ratio 59.23

Which analyst has the current highest performing score on KRMD (Repro Med Systems) with a proven track record?

KYLE ROSE

Which analyst has the current lower performing score on KRMD (Repro Med Systems) with a proven track record?

FRANK TAKKINEN

Which analyst has the most public recommendations on KRMD (Repro Med Systems)?

Kyle Rose works at CANACCORD and has 16 price targets and 11 ratings on KRMD

Which analyst is the currently most bullish on KRMD (Repro Med Systems)?

Frank Takkinen with highest potential upside - $0.83

Which analyst is the currently most reserved on KRMD (Repro Med Systems)?

Kyle Rose with lowest potential downside - -$1.17

Repro Med Systems in the News

KORU Medical Systems raises 2025 revenue outlook to $39.5M–$40.5M with accelerating international growth and new drug pipeline milestones

Earnings Call Insights: KORU Medical Systems (KRMD) Q2 2025 MANAGEMENT VIEW * CEO Linda M. Tharby highlighted that “we reached a historic milestone in Q2 with over $10 million in revenue” and emphasized momentum across all three strategic growth pillars: defending and growing the core domestic business, expanding internationally, and enabling delivery of additional drug...

Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates

Omnicell (OMCL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.51 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +45.16%. A quarter ago, it was expected that this...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?